Read More Pharma Industry News Oxford Biomedica (LSE: OXB) expands US manufacturing base with Durham viral vector facility buy Find out how Oxford Biomedica’s new US viral vector facility strengthens its CDMO leadership and growth trajectory. bySrinathOctober 7, 2025